Up to 21% of Asians are ultra-rapid 2D6 metabolizers, leading to:
A) A need to monitor drugs metabolized by 2D6 for toxicity
B) Increased dosages needed of drugs metabolized by 2D6, such as the selective serotonin reuptake inhibitors
C) Decreased conversion of codeine to morphine by CYP 2D6
D) The need for lowered dosages of drugs, such as beta blockers
Correct Answer:
Verified
Q1: Genetic testing for VCORC1 mutation to assess
Q2: Rifampin is a nonspecific CYP450 inducer that
Q3: Genetic polymorphisms account for differences in metabolism,
Q5: Carbamazepine has a Black Box Warning recommending
Q6: Pharmacogenetic testing is required by the U.S.
Q7: A provider may consider testing for CYP2D6
Q8: Patients who have a poor metabolism phenotype
Q9: A genetic variation in how the metabolite
Q10: Ultra-rapid metabolizers of drugs may have:
A) To
Q11: Warfarin resistance may be seen in patients
Unlock this Answer For Free Now!
View this answer and more for free by performing one of the following actions
Scan the QR code to install the App and get 2 free unlocks
Unlock quizzes for free by uploading documents